US Pentagon Purchases $210 Million in Cluster Shells from Israeli Company Tomer
The US Department of Defense has signed a massive contract to purchase advanced cluster shells from an Israeli company, marking one of the largest known deals between Washington and Tel Aviv.
Tomer, a state-owned arms company in Israel, will produce 155mm munitions for the US military over a three-year period. The deal comes amid growing concerns about cluster munitions' indiscriminate killing of civilians.
Cluster munitions have been widely criticized for their long-lasting impact on civilian populations. Unexploded shells can remain live for years, causing widespread harm to people and animals alike.
The Pentagon's decision has raised eyebrows among human rights advocates and critics of the arms trade. "These weapons are inherently indiscriminate," said Brian Castner, an Amnesty International investigator.
While some argue that cluster munitions have a limited role in modern warfare, others contend that their battlefield effectiveness cannot justify their humanitarian costs. "There's not a way to use them responsibly," said Castner.
In 2008, the Convention on Cluster Munitions banned the use and production of these weapons worldwide. However, the United States has never signed the treaty.
The Pentagon claims that its new cluster shells have undergone extensive testing to ensure they meet all performance requirements, including compliance with DoD policies. But critics say that real-world experience often differs from controlled testing, particularly in soft soil conditions or degraded fuses.
Elbit Systems, a parent company of IMI Systems, was initially involved in the development of the M999 cluster munition but canceled production after facing backlash from investors concerned about the ethics of its products.
The $210 million deal to Tomer marks an unusually large commitment by the US to Israel for cluster munitions. The Pentagon has previously signed smaller deals with Israeli companies but not one of this size.
Advocates argue that the sale is a blow to efforts to ban these indiscriminate weapons worldwide and highlights ongoing challenges in enforcing international humanitarian law.
The purchase comes amid growing tensions between Russia, Ukraine, China, Israel, India, Pakistan, and the United States over cluster munitions and other conventional arms.
The US Department of Defense has signed a massive contract to purchase advanced cluster shells from an Israeli company, marking one of the largest known deals between Washington and Tel Aviv.
Tomer, a state-owned arms company in Israel, will produce 155mm munitions for the US military over a three-year period. The deal comes amid growing concerns about cluster munitions' indiscriminate killing of civilians.
Cluster munitions have been widely criticized for their long-lasting impact on civilian populations. Unexploded shells can remain live for years, causing widespread harm to people and animals alike.
The Pentagon's decision has raised eyebrows among human rights advocates and critics of the arms trade. "These weapons are inherently indiscriminate," said Brian Castner, an Amnesty International investigator.
While some argue that cluster munitions have a limited role in modern warfare, others contend that their battlefield effectiveness cannot justify their humanitarian costs. "There's not a way to use them responsibly," said Castner.
In 2008, the Convention on Cluster Munitions banned the use and production of these weapons worldwide. However, the United States has never signed the treaty.
The Pentagon claims that its new cluster shells have undergone extensive testing to ensure they meet all performance requirements, including compliance with DoD policies. But critics say that real-world experience often differs from controlled testing, particularly in soft soil conditions or degraded fuses.
Elbit Systems, a parent company of IMI Systems, was initially involved in the development of the M999 cluster munition but canceled production after facing backlash from investors concerned about the ethics of its products.
The $210 million deal to Tomer marks an unusually large commitment by the US to Israel for cluster munitions. The Pentagon has previously signed smaller deals with Israeli companies but not one of this size.
Advocates argue that the sale is a blow to efforts to ban these indiscriminate weapons worldwide and highlights ongoing challenges in enforcing international humanitarian law.
The purchase comes amid growing tensions between Russia, Ukraine, China, Israel, India, Pakistan, and the United States over cluster munitions and other conventional arms.